BIOVENTUS INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 4.48 USD | -1.54% |
|
-1.97% | -14.99% |
| Mar. 13 | Craig-Hallum Adjusts Price Target on Bioventus to $9 From $6, Maintains Buy Rating | MT |
| Mar. 12 | Transcript : Bioventus Inc., Q4 2023 Earnings Call, Mar 12, 2024 |
Chart calendar Bioventus Inc.
59ad.g5A_DysMllU6v464FcjZFfB5pSgadnLwfBYeavbrW7I.sPgIRxNZ8w0Dy_fKI5y8OMEw9lhPJkueLX9JXqmDKp_P6k5gbW3ZEGvv-Q~19b2d970171636996e171420aba23963
Upcoming events on Bioventus Inc.
Past events on Bioventus Inc.
| 2024-03-12 08:30 am | Q4 2023 Earnings Call |
| 2024-03-12 07:30 am | Q4 2023 Earnings Release |
| 2023-11-07 08:30 am | Q3 2023 Earnings Call |
| 2023-11-07 07:00 am | Q3 2023 Earnings Release |
| 2023-09-28 01:50 pm | Cantor Global Healthcare Conference - Fireside Chat |
| 2023-09-13 08:50 am | Morgan Stanley Global Healthcare Conference |
| 2023-08-10 08:00 am | Canaccord Genuity Growth Conference |
| 2023-08-08 08:30 am | Q2 2023 Earnings Call |
| 2023-08-08 07:30 am | Q2 2023 Earnings Release |
| 2023-06-07 10:00 am | Annual General Meeting |
| 2023-05-16 05:00 pm | Q1 2023 Earnings Call |
| 2023-05-16 04:15 pm | Q1 2023 Earnings Release |
| 2023-03-31 08:30 am | Q4 2022 Earnings Call |
| 2023-03-31 07:30 am | Q4 2022 Earnings Release |
| 2023-01-11 08:15 pm | JP Morgan Healthcare Conference |
| 2022-11-08 12:30 pm | Q3 2022 Earnings Release |
| 2022-11-08 08:30 am | Q3 2022 Earnings Call |
| 2022-10-11 | North American Spine Society Meeting |
| 2022-09-14 11:10 am | Morgan Stanley Global Healthcare Conference - Fireside Chat |
| 2022-08-11 08:30 am | Interim 2022 Earnings Call |
Annual results
| Fiscal Period | December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 340 | 321 321 0.09% | 431 430 0.12% | 512 522 -1.84% | 512 501 2.29% | 528 |
|
EBITDA Million USD | Released Forecast Spread | 0,00 | 72,4 76,5 -5.31% | 80,8 78,3 3.12% | 66,3 75,1 -11.69% | 88,9 84,9 4.67% | 91,5 |
|
EBIT Million USD | Released Forecast Spread | 31,2 | 58,6 57,9 1.16% | 85,4 69,8 22.32% | 48,0 52,9 -9.39% | 81,0 77,5 4.64% | 78,5 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | 0,00 | 15,9 31,7 -49.86% | 7,62 3,22 136.72% | -264 -225 -17.38% | -121 -125 3.04% | -30,9 |
|
Net income Million USD | Released Forecast Spread | 0,00 | 4,38 31,4 -86.05% | 19,4 72,7 -73.36% | -159 20,8 -861.49% | -156 -130 -19.99% | -47,3 |
|
EPS USD | Released Forecast Spread | 0,00 | 0,89 0,25 256% | 0,43 1,62 -73.66% | -2,59 -2,23 -16.14% | -2,49 -2,32 -7.56% | -0,50 |
| Announcement Date | 06/10/20 | 25/03/21 | 10/03/22 | 31/03/23 | 12/03/24 | - |
Quarterly results
| Fiscal Period | December | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 130 130 0.1% | 117 118 -0.34% | 140 138 1.44% | 137 142 -3.19% | 126 133 -5.17% | 119 117 2.12% | 137 129 6.06% | 121 119 1.5% | 135 124 9.25% | 118 | 134 | 131 | 145 | 126 |
|
EBITDA Million USD | Released Forecast Spread | 28,5 22,4 27.43% | 7,11 6,90 3.06% | 22,9 22,5 1.79% | 22,7 25,3 -10.57% | 15,2 23,5 -35.27% | 17,0 11,6 46.27% | 28,2 20,0 40.47% | 21,7 15,2 42.75% | 22,0 18,1 21.81% | 12,9 | 25,6 | 22,8 | 29,6 | 16,7 |
|
EBIT Million USD | Released Forecast Spread | 22,3 15,9 40.43% | 1,92 6,29 -69.47% | 18,3 16,8 8.74% | 17,5 18,6 -5.65% | 11,8 16,8 -29.76% | 13,5 2,95 358.2% | 27,6 10,2 169.72% | 20,4 9,84 107.23% | 19,5 16,3 19.85% | 12,0 | 20,1 | 19,3 | 27,1 | 13,7 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -4,62 -9,02 48.8% | -19,9 -8,96 -122.45% | -6,77 -7,80 13.21% | 3,18 -6,92 146.03% | -49,7 -10,6 -367.9% | -100 -27,2 -268.32% | -6,49 -17,2 62.28% | -8,19 -19,2 57.43% | -8,41 -12,2 31.14% | -15,5 | -7,46 | -7,91 | 0,00 | -16,9 |
|
Net income Million USD | Released Forecast Spread | -11,3 1,00 -1227.7% | -174 -34,8 -401.28% | -3,68 | -7,30 -21,8 66.5% | -6,10 -16,7 63.5% | -22,0 | -10,2 | -11,2 | -3,90 | -16,9 | ||||
|
EPS USD | Released Forecast Spread | -0,01 0,06 -117.19% | -0,19 -0,12 -54.86% | -0,11 -0,08 -37.5% | 0,03 -0,08 140% | -0,52 -0,17 -215.15% | -2,24 -0,34 -567.72% | -0,07 -0,16 57.19% | -0,12 -0,30 60% | -0,10 -0,19 47.37% | -0,25 | -0,12 | -0,13 | 0,00 | -0,26 |
| Announcement Date | 10/03/22 | 10/05/22 | 11/08/22 | 08/11/22 | 31/03/23 | 16/05/23 | 08/08/23 | 07/11/23 | 12/03/24 | - | - | - | - | - |
More events
Past sector events for Bioventus Inc.
| Today | SHENZHEN YHLO BIOTECH CO., LTD.: Q4 2023 Earnings Release |
| 2024-03-26 | SHANDONG WEIGAO ORTHOPAEDIC DEVICE CO., LTD: Q4 2023 Earnings Release |
| 2024-03-26 02:00 am | SKAN GROUP AG: Q4 2023 Earnings Release |
| 2024-03-24 | APT MEDICAL INC.: Q4 2023 Earnings Release |
| 2024-02-28 04:05 pm | ZIMVIE INC.: Q4 2023 Earnings Release |
| 2024-02-28 04:05 pm | INARI MEDICAL, INC.: Q4 2023 Earnings Release |
| 2024-02-27 04:05 pm | TREACE MEDICAL CONCEPTS, INC.: Q4 2023 Earnings Release |
| 2024-02-27 04:05 pm | MASIMO CORPORATION: Q4 2023 Earnings Release |
| 2024-02-26 04:09 pm | SI-BONE, INC.: Q4 2023 Earnings Release |
| 2024-02-22 04:05 pm | PENUMBRA, INC.: Q4 2023 Earnings Release |
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- BVS Stock
- Calendar Bioventus Inc.
